4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prolonged warm ischemia time leads to severe renal dysfunction of donation-after-cardiac death kidney grafts

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Kidney transplantation with grafts procured after donation-after-cardiac death (DCD) has led to an increase in incidence of delayed graft function (DGF). It is thought that the warm ischemic (WI) insult encountered during DCD procurement is the cause of this finding, although few studies have been designed to definitely demonstrate this causation in a transplantation setting. Here, we use a large animal renal transplantation model to study the effects of prolonged WI during procurement on post-transplantation renal function. Kidneys from 30 kg-Yorkshire pigs were procured following increasing WI times of 0 min (Heart-Beating Donor), 30 min, 60 min, 90 min, and 120 min (n = 3–6 per group) to mimic DCD. Following 8 h of static cold storage and autotransplantation, animals were followed for 7-days. Significant renal dysfunction (SRD), resembling clinical DGF, was defined as the development of oliguria < 500 mL in 24 h from POD3-4 along with POD4 serum potassium > 6.0 mmol/L. Increasing WI times resulted in incremental elevation of post-operative serum creatinine that peaked later. DCD120min grafts had the highest and latest elevation of serum creatinine compared to all groups (POD5: 19.0 ± 1.1 mg/dL, p < 0.05). All surviving animals in this group had POD4 24 h urine output < 500 cc (mean 235 ± 172 mL) and elevated serum potassium (7.2 ± 1.1 mmol/L). Only animals in the DCD120min group fulfilled our criteria of SRD ( p = 0.003), and their renal function improved by POD7 with 24 h urine output > 500 mL and POD7 serum potassium < 6.0 mmol/L distinguishing this state from primary non-function. In a transplantation survival model, this work demonstrates that prolonging WI time similar to that which occurs in DCD conditions contributes to the development of SRD that resembles clinical DGF.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Chronic Kidney Disease.

          The definition and classification of chronic kidney disease (CKD) have evolved over time, but current international guidelines define this condition as decreased kidney function shown by glomerular filtration rate (GFR) of less than 60 mL/min per 1·73 m(2), or markers of kidney damage, or both, of at least 3 months duration, regardless of the underlying cause. Diabetes and hypertension are the main causes of CKD in all high-income and middle-income countries, and also in many low-income countries. Incidence, prevalence, and progression of CKD also vary within countries by ethnicity and social determinants of health, possibly through epigenetic influence. Many people are asymptomatic or have non-specific symptoms such as lethargy, itch, or loss of appetite. Diagnosis is commonly made after chance findings from screening tests (urinary dipstick or blood tests), or when symptoms become severe. The best available indicator of overall kidney function is GFR, which is measured either via exogenous markers (eg, DTPA, iohexol), or estimated using equations. Presence of proteinuria is associated with increased risk of progression of CKD and death. Kidney biopsy samples can show definitive evidence of CKD, through common changes such as glomerular sclerosis, tubular atrophy, and interstitial fibrosis. Complications include anaemia due to reduced production of erythropoietin by the kidney; reduced red blood cell survival and iron deficiency; and mineral bone disease caused by disturbed vitamin D, calcium, and phosphate metabolism. People with CKD are five to ten times more likely to die prematurely than they are to progress to end stage kidney disease. This increased risk of death rises exponentially as kidney function worsens and is largely attributable to death from cardiovascular disease, although cancer incidence and mortality are also increased. Health-related quality of life is substantially lower for people with CKD than for the general population, and falls as GFR declines. Interventions targeting specific symptoms, or aimed at supporting educational or lifestyle considerations, make a positive difference to people living with CKD. Inequity in access to services for this disease disproportionally affects disadvantaged populations, and health service provision to incentivise early intervention over provision of care only for advanced CKD is still evolving in many countries.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Delayed graft function: risk factors and implications for renal allograft survival.

            Delayed graft function (DGF) may be associated with diminished kidney allograft survival. We studied the risk factors that lead to nonimmediate function of a renal allograft and the consequences of DGF on short- and long-term renal transplant survival. Data from the U.S. Renal Data System were used to measure the relationships among cold ischemia time, delayed graft function, acute rejection, and graft survival in 37,216 primary cadaveric renal transplants (1985-1992). These relationships were investigated using the unconditional logistic and Cox multivariate regression methods. Cold ischemia time was strongly associated with DGF, with a 23% increase in the risk of DGF for every 6 hr of cold ischemia (P<0.001). Acute transplant rejection occurred more frequently in grafts with delayed function (37% vs. 20%; odds ratio=2.25, P=0.001). DGF was independently predictive of 5-year graft loss (relative risk=1.53, P<0.001). The presence of both early acute rejection and DGF portended a dismal 5-year graft survival rate of 35%. Zero-HLA mismatch conferred a 10-15% improvement in 1- and 5-year graft survival regardless of early functional status of the allograft. However, the 5-year graft survival rate in HLA-mismatched kidneys without DGF was significantly higher than that of zero-mismatched kidneys with DGF (63% vs. 51%; P<0.001). DGF independently portends a significant reduction in short- and long-term graft survival. Delayed function and early rejection episodes exerted an additive adverse effect on allograft survival. The deleterious impact of delayed function is comparatively more severe than that of poor HLA matching.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The distant organ effects of acute kidney injury.

              Despite the availability of renal replacement therapy, acute kidney injury (AKI) is associated with high mortality and morbidity. In humans, it is difficult to determine whether AKI is a cause or consequence of excess morbidity. In animal models, however, it is increasingly clear that AKI induces distant organ dysfunction. Identified pathways include inflammatory cascades, apoptosis, the induction of remote oxidative stress, and differential molecular expression. Specifically, growing evidence implicates renal injury as an instigator and multiplier of pulmonary, cardiac, hepatic, and neurologic dysfunction. Accurate identification of these pathways will be critical in developing targeted therapies to improve outcomes in AKI. The purpose of this review is to summarize both clinical and preclinical studies of AKI and its role in distant organ injury.
                Bookmark

                Author and article information

                Contributors
                lisa.robinson@sickkids.ca
                markus.selzner@uhn.ca
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                9 September 2021
                9 September 2021
                2021
                : 11
                : 17930
                Affiliations
                [1 ]GRID grid.231844.8, ISNI 0000 0004 0474 0428, Soham and Shaila Ajmera Family Transplant Centre, University of Toronto General Surgery and Multi-Organ Transplant Program, Toronto General Hospital, , University Health Network, ; 585 University Avenue, 11 PMB-178, Toronto, ON M5G 2N2 Canada
                [2 ]Canadian Donation and Transplantation Research Program, Edmonton, AB Canada
                [3 ]GRID grid.17063.33, ISNI 0000 0001 2157 2938, Institute of Medical Science, , University of Toronto, ; Toronto, ON Canada
                [4 ]GRID grid.410718.b, ISNI 0000 0001 0262 7331, General, Visceral and Transplantation Surgery, , University Hospital Essen, ; Essen, Germany
                [5 ]GRID grid.22937.3d, ISNI 0000 0000 9259 8492, Department of General Surgery, , Medical University of Vienna, ; Vienna, Austria
                [6 ]GRID grid.17063.33, ISNI 0000 0001 2157 2938, Laboratory Medicine and Pathobiology, Toronto General Hospital, , University of Toronto, ; Toronto, ON Canada
                [7 ]GRID grid.231844.8, ISNI 0000 0004 0474 0428, Department of Medicine, Division of Nephrology, , University Health Network, ; Toronto, ON Canada
                [8 ]GRID grid.17063.33, ISNI 0000 0001 2157 2938, Departments of Surgery (Urology) and Physiology, The Hospital for Sick Children, , University of Toronto, ; Toronto, ON Canada
                [9 ]GRID grid.42327.30, ISNI 0000 0004 0473 9646, Program in Developmental and Stem Cell Biology, , The Hospital For Sick Children Research Institute, ; Toronto, ON Canada
                [10 ]GRID grid.42327.30, ISNI 0000 0004 0473 9646, Division of Nephrology, , The Hospital for Sick Children, ; 555 University Avenue, Toronto, ON M5G 1X8 Canada
                [11 ]GRID grid.42327.30, ISNI 0000 0004 0473 9646, Program in Cell Biology, , The Hospital for Sick Children Research Institute, ; Toronto, ON Canada
                Article
                97078
                10.1038/s41598-021-97078-w
                8429572
                34504136
                6713e36e-698e-4686-b364-2e3ae62987ea
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 19 March 2021
                : 9 August 2021
                Categories
                Article
                Custom metadata
                © The Author(s) 2021

                Uncategorized
                acute inflammation,translational research,kidney diseases
                Uncategorized
                acute inflammation, translational research, kidney diseases

                Comments

                Comment on this article